Results 171 to 180 of about 143,948 (293)

Impact of Lower Urinary Tract Symptoms on Daily Life in Individuals With Co‐Existence Overactive and Underactive Bladder, Overactive Bladder, and Underactive Bladder

LUTS: Lower Urinary Tract Symptoms, Volume 17, Issue 5, September 2025.
ABSTRACT Objectives To explore the particular lower urinary tract symptoms (LUTS) that impact daily life in co‐existent overactive and underactive bladder (COUB), overactive bladder (OAB), and underactive bladder (UAB) as symptom syndromes. Methods Using data from a nationwide, cross‐sectional internet survey of adults aged ≥ 20 conducted in Japan ...
Noritoshi Sekido, Kenji Omae, Nobuhiro Haga, Yasue Kubota, Motoaki Saito, Ryuji Sakakibara, Mikako Yoshida, Takahiko Mitsui, Naoya Masumori, Satoru Takahashi   +9 more
wiley   +1 more source

A CLINICAL CLASSIFICATION OF SEVERITY OF BENIGN PROSTATIC HYPERPLASIA

, 1993
Yukio Homma, Chieko Imajo, Satoru Takahashi, Yoshio Aso   +3 more
openalex   +2 more sources

Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy

BJUI Compass, Volume 6, Issue 8, August 2025.
Abstract Objectives To evaluate the efficacy and safety of bilateral vas deferens sutures in preventing postoperative inguinal hernia after prostatectomy for clinically localized prostate cancer. Materials and Methods This retrospective study included 282 patients with localized prostate cancer who underwent open or laparoscopic radical prostatectomy ...
Kenichi Hata, Yuma Goto, Masaki Hashimoto, Yusuke Takahashi, Yuki Takiguchi, Yuya Iwamoto, Shun Saito, Ayaka Kawaharada, Yuki Enei, Keigo Sakanaka, Kazuhiro Takahashi, Akira Hisakane, Taisuke Yamazaki, Keiji Yasue, Soichiro Aoki, Kanako Kasai, Takafumi Yanagisawa, Shunsuke Tsuzuki, Gen Ishii, Toshihiro Yamamoto, Hiroshi Sasaki, Jun Miki, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Kenta Miki, Takahiro Kimura   +26 more
wiley   +1 more source

Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia [PDF]

, 1981
Jüngst, Dieter, Karl, Hans Josef, Lazik, E., Tauber, R.   +3 more
core   +1 more source

Visual Laser Ablation of the Prostate (VLAP) for Benign Prostatic Hyperplasia

, 1994
Τοyoaki Uchida
openalex   +2 more sources

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 992-1001, August 1, 2025.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source

Management of Benign Prostatic Hypertrophy-Related Urinary Retention: Current Trends and Perspectives

Urology Journal, 2009
The failure of prostate-directed treatment modalities to help all men or all symptoms has questioned the longstanding assumption that the prostate is at the root of all male urinary symptoms, and a correlation between urinary bladder function and ...
Konstantinos Stamatiou
doaj  

Beta-sitosterols for benign prostatic hyperplasia

, 1999
Timothy J Wilt, Areef Ishani, Roderick MacDonald, Gerold Stark, Cynthia D. Mulrow, Joseph Lau   +5 more
openalex   +2 more sources

Pharmacological and Therapeutic Properties of the Caucasian Whortleberry (Vaccinium arctostaphylos L.): An Overview of the New Findings

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
This review covers the ethnomedical applications, phytochemical composition, and pharmacological properties of various extracts from different parts of V. arctostaphylos, with a particular focus on the aerial parts and fruits of this medicinal plant. In Iranian traditional medicine, V.
Hesam Bighamanganeh, Maryam Salabati, Abbas Khalilpour, Mohsen Akbaribazm, Nabi Akbarnezhad   +4 more
wiley   +1 more source

Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
Eugenol (Eug), a volatile phenolic bioactive compound with formula of C10H12O2 have been reported with anticancer, antidiabetic, cardio‐ and pulmonary protective role. Moreover, it has the ability to improve gut health and prevent neurodegenerative disorders. According to WHO, the safe dose of Eug is 2.5 mg/kg for consumption.
Ahmad Mujtaba Noman, Muhammad Tauseef Sultan, Aimen Mazhar, Waqas Ahmad Khan, Muhammad Imran, Muzzamal Hussain, Ehab M. Mostafa, Ahmed H. El‐Ghorab, Mohammed M. Ghoneim, Samy Selim, Mohamed A. Abdelgawad, Entessar Al Jbawi, Suliman A. Alsagaby, Waleed Al Abdulmonem   +13 more
wiley   +1 more source